NanoLife Holdings is focused on its mission of the development of a Global Initiative, the commitment of the world's scientific, economic, and political prowess to Saving Lives from the Ravages of Cancer. NanoLife is facilitating advanced developments in radiotherapy for cancer.
NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.
Nanologica engineers nanoporous materials for use in a range of industries, from pharmaceuticals to petrochemicals. Their patented technique enables them to create structures that have novel properties and functions based on their size, shape or composition that boost efficiency and lower manufacturing costs.
Specializes in the production of nanomaterials (nanoparticles and nanopowders) having complex composition and exacting particle size and particle size distribution and tailored surface characteristics.
The Nanomaterials Innovation Center's mission is to enable technology transfer in inorganic nanomaterials science and microwave processing technology by providing a unique research and prototyping center that encourages and supports market driven collaborations between universities, industry and private labs. The NanoMaterials Innovation Center (NMIC) is a wholly-owned subsidiary of Alfred Technology Resources, Inc. The NMIC provides universities and industry with critical technology resources in microwave processing, inorganic nanomaterials, and nanomaterials processing.
The company's mission is to enable their customers to evaluate and understand the mechanical performance of their materials on the micro- and nano-scales. With field experts in nanomechanical testing, data acquisition, system integration, and software development on their staff, tehy are well positioned to provide you with the most accurate results along with leading edge characterization.
NanoMedical Systems (NMS) is a startup company, which will commercialize the patented research of Dr. Mauro Ferrari at the University of Texas Health Science Center in Houston, a sponsored research site and a source of licensed IP for NMS. The company's Personalized Molecular Drug-delivery System (PMDS) is a small drug delivery device that is implanted subcutaneously (just under the skin) for slow and consistent release of a therapeutic agent over many weeks or months. A nanochannel delivery system (nDS) embodied on a silicon chip regulates the flow of therapeutic molecules.
Nanomet is a Russian manufacturer of colloidal metal nanoparticles with a biochemical synthesis method. The company offers mutual research and development programs where their nanoparticles can be used.
Nanometics is a chemical research company dedicated to the development of novel raw materials for the personal care and textile industries. In addition, there are several ongoing collaborations in projects relating to biomedical imaging, chiral molecular switches for quantum computing and supramolecular chemistry for neural prosthetics.
Nanometrics' product lines offer an extensive array of proprietary technologies in optics, software and systems integration designed to meet the process control requirements of today's advanced semiconductor technologies.